Clinical Trials Browser

Phase 2 × OTHER × vadimezan × Clear all

NCT01071928 2015-08-19

Second-Line Docetaxel + ASA404 for Advanced Urothelial Carcinoma

Phase 2 Withdrawn

Carcinoma, Transitional Cell

NCT01057342 2013-04-10

Paclitaxel, Carboplatin, and Dimethylxanthenone Acetic Acid in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Phase 2 Completed

Lung Neoplasms